Mineralocorticoid Receptors in Immune Cells; Emerging Role in Cardiovascular Disease

作者: Nicholas C. Bene , Pilar Alcaide , Henry H. Wortis , Iris Z. Jaffe

DOI: 10.1016/J.STEROIDS.2014.04.005

关键词: Pathophysiology of hypertensionMacrophageLymphocyteT lymphocyteImmunologyAntigenPathogenesisMineralocorticoid receptorImmune systemBiology

摘要: Mineralocorticoid receptors (MRs) contribute to the pathophysiology of hypertension and cardiovascular disease in humans. As such, MR antagonists improve outcomes but molecular mechanisms remain unclear. The actions kidney increase blood pressure are well known, recent identification MRs immune cells has led novel discoveries pathogenesis that reviewed here. regulates macrophage activation pro-inflammatory M1 phenotype this process contributes fibrosis response mouse models stroke. T lymphocytes have recently been implicated development models. vivo promotes lymphocyte differentiation Th1 Th17 subsets while decreasing number anti-inflammatory regulatory lymphocytes. mechanism likely involves antigen presenting dendritic subsequently regulate Th1/Th17 polarization by production cytokines. Alteration balance between helper atherosclerosis associated complications. B also express specific lymphocyte-derived antibodies modulate progression atherosclerosis. However, role function remains be explored. Overall, studies identified new which may organ damage patients with risk factors. Conversely, inhibition leukocyte protective effects antagonist drugs patients. Further understanding could yield drug targets for disease.

参考文章(77)
Ernesto L. Schiffrin, Immune modulation of resistance artery remodelling. Basic & Clinical Pharmacology & Toxicology. ,vol. 110, pp. 70- 72 ,(2012) , 10.1111/J.1742-7843.2011.00760.X
Michael G. Usher, Sheng Zhong Duan, Christine Y. Ivaschenko, Ryan A. Frieler, Stefan Berger, Günther Schütz, Carey N. Lumeng, Richard M. Mortensen, Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice Journal of Clinical Investigation. ,vol. 120, pp. 3350- 3364 ,(2010) , 10.1172/JCI41080
Wei Chen, Nikolaos G. Frangogiannis, The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Failure Reviews. ,vol. 15, pp. 415- 422 ,(2010) , 10.1007/S10741-010-9161-Y
Gabriela Kania, Przemyslaw Blyszczuk, Urs Eriksson, Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends in Cardiovascular Medicine. ,vol. 19, pp. 247- 252 ,(2009) , 10.1016/J.TCM.2010.02.005
Yohann Rautureau, Pierre Paradis, Ernesto L. Schiffrin, Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells Steroids. ,vol. 76, pp. 834- 839 ,(2011) , 10.1016/J.STEROIDS.2011.02.015
Nicolette Farman, Brigitte Bocchi, Mineralocorticoid selectivity: Molecular and cellular aspects Kidney International. ,vol. 57, pp. 1364- 1369 ,(2000) , 10.1046/J.1523-1755.2000.00976.X
Shlomo Keidar, Tony Hayek, Marielle Kaplan, Elsa Pavlotzky, Shadi Hamoud, Raymond Coleman, Michael Aviram, Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice. Journal of Cardiovascular Pharmacology. ,vol. 41, pp. 955- 963 ,(2003) , 10.1097/00005344-200306000-00019
Graeme A. Deuchar, Danielle McLean, Patrick W. F. Hadoke, David G. Brownstein, David J. Webb, John J. Mullins, Karen Chapman, Jonathan R. Seckl, Yuri V. Kotelevtsev, 11β-Hydroxysteroid Dehydrogenase Type 2 Deficiency Accelerates Atherogenesis and Causes Proinflammatory Changes in the Endothelium in Apoe−/− Mice Endocrinology. ,vol. 152, pp. 236- 246 ,(2011) , 10.1210/EN.2010-0925